InvestSMART

MedAdvisor Limited (ASX: MDR) - Announcements

Current share price for MDR : $0.022 0.002 (10%)+

ASX company news and announcements for MedAdvisor Limited (MDR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All MedAdvisor Limited (MDR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than MedAdvisor Limited (MDR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for MedAdvisor Limited (MDR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- September Quarterly Activities Report and Appendix 4C 5 Oct 2016 1:27PM $0.038 $0.022 fallen by 42.11%
- Publication of Research Note 4 Oct 2016 10:08AM $0.039 $0.022 fallen by 43.59%
- Listing Rule 4.10.19 Statement 29 Sep 2016 3:53PM $0.039 $0.022 fallen by 43.59%
- Annual Report to Shareholders (68 pages) 23 Sep 2016 11:57AM $0.045 $0.022 fallen by 51.11%
- Appendix 4G (12 pages) 23 Sep 2016 12:19AM $0.045 $0.022 fallen by 51.11%
- Notice of Annual General Meeting / Proxy (24 pages) 23 Sep 2016 12:19AM $0.045 $0.022 fallen by 51.11%
- MedAdvisor features in CommSec Executive Series 22 Sep 2016 3:36PM $0.045 $0.022 fallen by 51.11%
- Acquisition and Fund Raising Presentation 12 Sep 2016 10:19AM $0.038 $0.022 fallen by 42.11%
- Notice of General Meeting and Proxy 9 Sep 2016 9:48AM $0.038 $0.022 fallen by 42.11%
- MedAdvisor to Acquire Healthnotes to Accelerate Growth 31 Aug 2016 9:08AM $0.036 $0.022 fallen by 38.89%
- Trading Halt 29 Aug 2016 9:09AM $0.036 $0.022 fallen by 38.89%
- Appendix 4E and Preliminary Financial Report 26 Aug 2016 2:56PM $0.036 $0.022 fallen by 38.89%
- MedAdvisor launches new NDSS feature with Diabetes Aust 25 Aug 2016 10:47AM $0.035 $0.022 fallen by 37.14%
- Glaucoma Australia Partnership to assist 300,000 Australians 15 Aug 2016 10:07AM $0.035 $0.022 fallen by 37.14%
- Quarterly Activities Report and Appendix 4C - June 16 29 Jul 2016 2:56PM $0.040 $0.022 fallen by 45%
- Major Biopharmaceutical Signs to Patient Engagement Program 1 Jul 2016 8:41AM $0.038 $0.022 fallen by 42.11%
- Strong Growth in Key Business Drivers 29 Jun 2016 8:27AM $0.038 $0.022 fallen by 42.11%
- GlaxoSmithKline Extends Service Agreement with MedAdvisor 16 Jun 2016 9:54AM $0.044 $0.022 fallen by 50%
- Sales Channel Secured with Arrow Pharmaceuticals 1 Jun 2016 11:56AM $0.036 $0.022 fallen by 38.89%
- MedAdvisor Updated Share Trading Policy 31 May 2016 10:05AM $0.033 $0.022 fallen by 33.33%
- Novartis Pharmaceuticals Australia to use MedAdvisor 30 May 2016 10:31AM $0.032 $0.022 fallen by 31.25%
- Singapore Biotech Invest Presentation 3 May 2016 3 May 2016 1:14PM $0.030 $0.022 fallen by 26.67%
- Shareholder Update Resignation of Company Secretary 29 Apr 2016 1:49PM $0.030 $0.022 fallen by 26.67%
- MDR Quarterly Activities Report and Appendix 4C 29 Apr 2016 1:47PM $0.030 $0.022 fallen by 26.67%
- MDR Featured in CommSec Executive Series Interview 19 Apr 2016 9:28AM $0.028 $0.022 fallen by 21.43%

701 - 725 of 761 results

Page 29 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.